Mystic Connecticut based Enko Chem is raising $69,493,377.00 in New Equity Investment.
Mystic, CT – According to filings with the U.S. Securities and Exchange Commission, Enko Chem is raising $69,493,377.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jacqueline Heard played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Enko Chem
Enko designs safe and sustainable solutions to farmers biggest crop threats today, from pest resistance to new diseases. By applying the latest drug discovery and development approaches from pharma to plants, Enko is bringing an innovation model to agriculture and meeting farmers evolving needs. Founded in 2017 and led by a team of proven scientists, entrepreneurs and agriculture industry veterans, Enko is backed by investors including the Bill & Melinda Gates Foundation, Anterra Capital, Finistere Ventures, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, and Rabo Food & Agri Innovation Fund.
To learn more about Enko Chem, visit http://enkochem.com/
Contact:
Jacqueline Heard, Chief Executive Officer
860-287-7831
jacqueline.heard@enkochem.com
https://www.linkedin.com/in/jacqueline-heard-a0869318/
SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved